MedTrace Logo

Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms

NCT06787443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-01-22

No results posted yet for this study

Summary

The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.

Conditions

  • Menopausal Symptoms

Interventions

DIETARY_SUPPLEMENT

Placebo

Eligible subjects will receive Placebo to take daily for five weeks

DIETARY_SUPPLEMENT

Dietary Supplement with Proprietary Herbal Extract Blend and GABA

Eligible subjects will receive active product to take daily for five weeks

Sponsors & Collaborators

  • Olly, PBC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-10
Primary Completion
2024-06-24
Completion
2024-06-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06787443 on ClinicalTrials.gov